Expression of matrix metalloproteinase-9 in prostate cancer. Preliminary experience;Expresión de metaloproteasa de matriz 9 en el cáncer de próstata. Experiencia preliminar

Archivos Espanoles de Urologia

Volumn 63, Issue 2, 2010, Pages 119-124

  Rodriguez, Ivan Gonzalez ^a   Del Fresno, Manuel Rivas ^a   Ugarteburu, Rodrigo Gil ^a   Arriaga, Patricia Gonzalez ^a   Lopez Cima, Felicitas ^a   Samoano, Ana Fernandez ^a   Fernandez, Valentin Muruamendiaraz ^a   García, Isabel Fernandez ^a   Perez Carral, Jose Ramon ^a   Tardon, Adonina ^a  

^a HOSPITAL DE CABUEÑES   (Spain)

Author keywords

Diagnostic; Markers; Metalloproteinase 9; Prostate cancer; PSA

Indexed keywords

GELATINASE B; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

AGED; ARTICLE; BIOSYNTHESIS; BLOOD; HUMAN; MALE; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; PROSTATE TUMOR;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77956211764     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Gómez Veiga F, Ponce Reixa J, Barbagelata López A, Fernández Rosado E, González Martín M. Papel actual del Antígeno Prostático Específico y otros marcadores en el Diagnóstico del Cáncer de Próstata. Arch Esp Urol, 2006; 59 (10): 1069-1082
2. Brawer MK. Prostatic-specific antigen: current status. Cancer J Clin, 1999; 49: 264.
3. Puente X, Sánchez L, Overall C M, and López-Otín C. Human and mouse proteases: a comparative genomic approach. Nat Rev Genet, 2003; 9: 407-415
4. Folgueras AR, Pendás AM, Sánchez LM, López- Otín C. Matrix metalloproteinases in cancer: From new functions to improved inhibition strategies. Int Dev Biol, 2004; 48: 411-424
5. Shafiro SD. Matrix metalloproteinase degradation of extracelular matrix: biological consequences. Curr Opin Cell Biol, 1998; 10: 602-608
6. Seghal I and Thompson TC. Novel regulation of Type IV Collagenase (Matrix Metalloprotease -9 and -2) activity transforming Growth Factor-β1 in Cancer Cll Lines. Mol Biol Cell, 1999; 10(2) 407-416
7. Grieu F, Qi Li W and Iacopetta B. Genetic polimorfisms in the MMP-2 and the MMP-9 gene and breast cancer phenotype. Breast Cancer res treat 2004; 88 (3): 197-204.
8. Soria de González A, Díaz EI, Guber RS, Arias NN, Ruiz de Martínez N. Niveles séricos de metaloproteasa-9 en mujeres con patologías mamarias. Acta Bioquím. Clín. Latinoam, 2005; 39 (2): 157-161
9. Hu Z, Huo X, Lu D, Qian J, Zhou J, Chen Y, et al. Functional Polymorphisms of Matrix Metalloproteinase-9 are associated with Risk of occurrence and metastasis of lung cancer. Clin Cancer Res, 2005; 11 (15): 5433-5439
10. Hueslin MJ, Yna J, Johnson MR, Weiss H, Diasio RB, and Urist MM. Role of Matrix Metalloproteinase in Colorrectal carcinogenesis. Annals of Surg, 2001; 233 (6): 786-792
11. Kanayama H. Matrix Metalloproteinases and bladder cancer. J Med Invest, 2001; 48: 31-43.
12. Awakura Y, Ito N, Nakamura E, Takahashi T, Kotani H, Mikami Y, et al. Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in Japanese population. Cancer Letters, 2006; 241: 59-63.
13. Sauer CG, Kappeler A, Späth M, Kaden JJ, Michel MS, Mayer D, Bleyl, et al. Expresion and activity of matrix metalloproteinases-2 and -9 in serum, core biopsies and tissue specimens of prostate cancer patients. Virchows Arch, 2004; 444 (6): 518-526
14. Zhang L, Shi J, Feng J, Klocker H, Lee C, Zhang J. Type IV collagenase (matrix metalloproteinase-2 and -9 in prostate cancer. Prostate Cancer Prostatic, Dis 2004; 7 (4): 327-332
15. Morgia G, Falsaperla M, Malaponte G, Madonia M, Indelicato M, Travali S, et al. Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) as markers of prostate cancer. Urol Res, 2005; 33 (1): 44-50.
16. Santos Arrontes D, Luján Galán M, Pascual Mateo C, Chiva Robles V, Fernández González I y Berenguer Sánchez A. Análisis descriptivo de los efectos adversos de la biopsia transrectal prostática en 603 procedimientos. Arch Esp Urol, 2004; 57 (6): 601-605
17. Naughton CK, Miller DC, Mager DE, Ornstein DK and Catalona WJ. A prospective Randomiced Trial comparing 6 versus 12 prostate biopsy cores: Impact on Cancer Detection. J Urol, 2000; 164: 388-392
18. Trilla E y. Morote J. Cáncer de Próstata: Nuevas técnicas diagnósticas. Estado actual de la biopsia de próstata. Arch Esp Urol, 2006; 59 (10): 945-952